{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:37:41Z","timestamp":1794569861452,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The number of studies describing the use of whole-body magnetic resonance imaging (WB-MRI) for screening of malignant tumours in asymptomatic subjects is increasing. Our aim is to review the methodologies used and the results of the published studies on per patient and per lesion analysis, and to provide recommendations on the use of WB-MRI for cancer screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>We identified 12 studies, encompassing 6214 WB-MRI examinations, which provided the rates of abnormal findings and findings suspicious for cancer in asymptomatic subjects, from the general population. Eleven of 12 studies provided imaging protocols that included T1- and T2-weighted sequences, while only five included diffusion weighted imaging (DWI) of the whole body. Different categorical systems were used for the classification and the management of abnormal findings.<\/jats:p>\n                    <jats:p>Of 17,961 abnormal findings reported, 91% were benign, while 9% were oncologically relevant, requiring further investigations, and 0.5% of lesions were suspicious for cancer.<\/jats:p>\n                    <jats:p>A per-subject analysis showed that just 5% of subjects had no abnormal findings, while 95% had abnormal findings. Findings requiring further investigation were reported in 30% of all subjects, though in only 1.8% cancer was suspected. The overall rate of histologically confirmed cancer was 1.1%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>WB-MRI studies of cancer screening in the asymptomatic general population are too heterogeneous to draw impactful conclusions regarding efficacy. A 5-point lesion scale based on the oncological relevance of findings appears the most appropriate for risk-based management stratification. WB-MRI examinations should be reported by experienced oncological radiologists versed on WB-MRI reading abnormalities and on onward referral pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40644-020-00315-0","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T09:02:55Z","timestamp":1589187775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-4760","authenticated-orcid":false,"given":"Fabio","family":"Zugni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar Roshanali","family":"Padhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Eugene","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bellomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"315_CR1","doi-asserted-by":"crossref","unstructured":"Petralia G, Padhani AR, Pricolo P, Zugni F, Martinetti M, Summers PE, et al. Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med. 2018.","DOI":"10.1007\/s11547-018-0955-7"},{"key":"315_CR2","doi-asserted-by":"publisher","first-page":"W336","DOI":"10.2214\/AJR.17.17984","volume":"209","author":"M Morone","year":"2017","unstructured":"Morone M, Bali MA, Tunariu N, Messiou C, Blackledge M, Grazioli L, et al. Whole-body MRI: current applications in oncology. Am J Roentgenol. American Roentgen Ray Society. 2017;209:W336\u201349.","journal-title":"Am J Roentgenol. American Roentgen Ray Society"},{"key":"315_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, et al. Role of magnetic resonance imaging in the Management of Patients with Multiple Myeloma: a consensus statement. J Clin Oncol. 2015;33:657\u201364.","journal-title":"J Clin Oncol"},{"key":"315_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14827","volume":"178","author":"A Chantry","year":"2017","unstructured":"Chantry A, Kazmi M, Barrington S, Goh V, Mulholland N, Streetly M, et al. Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol Wiley. 2017;178:380\u201393.","journal-title":"Br J Haematol Wiley"},{"key":"315_CR5","first-page":"5","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. Radiological Society of North America. 2019;291:5\u201313.","journal-title":"Radiology. Radiological Society of North America"},{"key":"315_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejca.2005.10.008","volume":"42","author":"C M\u00fcller-Horvat","year":"2006","unstructured":"M\u00fcller-Horvat C, Radny P, Eigentler TK, Sch\u00e4fer J, Pfannenberg C, Horger M, et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer. 2006;42:342\u201350.","journal-title":"Eur J Cancer"},{"key":"315_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","volume":"43","author":"C Pfannenberg","year":"2007","unstructured":"Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43:557\u201364.","journal-title":"Eur J Cancer"},{"key":"315_CR8","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1007\/s00330-013-2968-x","volume":"23","author":"G Petralia","year":"2013","unstructured":"Petralia G, Padhani A, Summers P, Alessi S, Raimondi S, Testori A, et al. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients? Eur Radiol. 2013;23:3466\u201376.","journal-title":"Eur Radiol"},{"key":"315_CR9","doi-asserted-by":"crossref","unstructured":"Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, et al. Malignant Melanoma S3-Guideline \u201cDiagnosis, Therapy and Follow-up of Melanoma.\u201d JDDG J der Dtsch Dermatologischen Gesellschaft 2013;11:1\u2013116.","DOI":"10.1111\/ddg.12113_suppl"},{"key":"315_CR10","doi-asserted-by":"crossref","unstructured":"Dummer R, Siano M, Hunger RE, Lindenblatt N, Braun R, Michielin O, et al. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2016;146.","DOI":"10.4414\/smw.2016.14279"},{"key":"315_CR11","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00256-014-1903-9","volume":"43","author":"G Shen","year":"2014","unstructured":"Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol Springer Nature. 2014;43:1503\u201313.","journal-title":"Skeletal Radiol Springer Nature"},{"key":"315_CR12","volume-title":"EAU -ESTRO -SIOG guidelines on prostate Cancer","author":"N Mottet","year":"2016","unstructured":"Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, et al. EAU -ESTRO -SIOG guidelines on prostate Cancer. 2016."},{"key":"315_CR13","volume-title":"Management of Patients with advanced prostate Cancer: report of the advanced prostate Cancer consensus conference 2019","author":"S Gillessen","year":"2020","unstructured":"Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, et al. Management of Patients with advanced prostate Cancer: report of the advanced prostate Cancer consensus conference 2019. Eur Urol. Elsevier B.V.; 2020."},{"key":"315_CR14","doi-asserted-by":"crossref","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, et al. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. American Society of Clinical Oncology (ASCO); 2020;JCO.19.02757.","DOI":"10.1200\/JOP.19.00699"},{"key":"315_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","volume":"71","author":"AR Padhani","year":"2017","unstructured":"Padhani AR, Lecouvet FE, Tunariu N, Koh D-M, De Keyzer F, Collins DJ, et al. METastasis reporting and data system for prostate Cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate Cancer. Eur Urol Elsevier. 2017;71:81\u201392.","journal-title":"Eur Urol Elsevier"},{"key":"315_CR16","doi-asserted-by":"crossref","unstructured":"Petralia G, Padhani AR. Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications. Magn. Reson. Imaging Clin. N. Am. W.B. Saunders; 2018. p. 495\u2013507.","DOI":"10.1016\/j.mric.2018.06.003"},{"key":"315_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2017.03.001","volume":"77","author":"M Kosmin","year":"2017","unstructured":"Kosmin M, Makris A, Joshi PV, Ah-See M-L, Woolf D, Padhani AR. The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer. Eur J Cancer. 2017;77:109\u201316.","journal-title":"Eur J Cancer"},{"key":"315_CR18","doi-asserted-by":"crossref","unstructured":"Zugni F, Ruju F, Pricolo P, Alessi S, Iorfida M, Colleoni MA, et al. The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer. PLoS One. 2018;Article in.","DOI":"10.1371\/journal.pone.0205251"},{"key":"315_CR19","doi-asserted-by":"crossref","unstructured":"Peccatori FA, Codacci-Pisanelli G, Del Grande M, Scarfone G, Zugni F, Petralia G. Whole body MRI for systemic staging of breast cancer in pregnant women. Breast. 2017;35.","DOI":"10.1016\/j.breast.2017.07.014"},{"key":"315_CR20","doi-asserted-by":"crossref","unstructured":"Montagna E, Peccatori F, Petralia G, Tomasi Cont N, Iorfida M, Colleoni M. Whole-body magnetic resonance imaging, metastatic breast cancer and pregnancy: A case report. Breast. Churchill Livingstone; 2014. p. 295\u2013296.","DOI":"10.1016\/j.breast.2014.01.012"},{"key":"315_CR21","doi-asserted-by":"crossref","unstructured":"Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, et al. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Clin Cancer Res. American Association for Cancer Research; 2014;20:2984\u20132993.","DOI":"10.1158\/1078-0432.CCR-13-3355"},{"key":"315_CR22","doi-asserted-by":"crossref","unstructured":"Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, et al. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET\/CT-Controlled Prospective Study in 64 Patients. Clin Cancer Res. American Association for Cancer Research (AACR); 2015;21:2506\u201313.","DOI":"10.1158\/1078-0432.CCR-14-2454"},{"key":"315_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0001-2998(86)80027-7","volume":"16","author":"WR Hendee","year":"1986","unstructured":"Hendee WR, Marc EF. ALARA and an integrated approach to radiation protection. Semin Nucl Med Elsevier BV. 1986;16:142\u201350.","journal-title":"Semin Nucl Med Elsevier BV"},{"key":"315_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(19)30056-1","volume":"4","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Beare S, Bhatnagar G, Blunt D, Boavida P, et al. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective streamline C trial. Lancet Gastroenterol Hepatol Elsevier Ltd. 2019;4:529\u201337.","journal-title":"Lancet Gastroenterol Hepatol Elsevier Ltd"},{"key":"315_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S2213-2600(19)30090-6","volume":"7","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Ball S, Beare S, Bhatnagar G, Bhowmik A, et al. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective streamline L trial. Lancet Respir Med Lancet Publishing Group. 2019;7:523\u201332.","journal-title":"Lancet Respir Med Lancet Publishing Group"},{"key":"315_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejrad.2013.11.017","volume":"83","author":"B Li","year":"2014","unstructured":"Li B, Li Q, Nie W, Liu S. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. Eur J Radiol Elsevier BV. 2014;83:338\u201344.","journal-title":"Eur J Radiol Elsevier BV"},{"key":"315_CR27","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Genetic\/Familial High-Risk Assessment [Internet]. 2018. Available from: http:\/\/bit.ly\/1Nubll0."},{"key":"315_CR28","doi-asserted-by":"crossref","unstructured":"Kratz CP, Achatz MI, Brugi\u00e8res L, Frebourg T, Garber JE, Greer M-LC, et al. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. American Association for Cancer Research (AACR); 2017;23:e38\u201345.","DOI":"10.1158\/1078-0432.CCR-17-0408"},{"key":"315_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","volume":"11","author":"KA McBride","year":"2014","unstructured":"McBride KA, Ballinger ML, Killick E, Kirk J, Tattersall MHN, Eeles RA, et al. Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol. 2014;11:260\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"315_CR30","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","volume":"17","author":"A Villani","year":"2016","unstructured":"Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol Elsevier. 2016;17:1295\u2013305.","journal-title":"Lancet Oncol Elsevier"},{"key":"315_CR31","doi-asserted-by":"crossref","unstructured":"Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, et al. Von Hippel\u2013Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res. American Association for Cancer Research (AACR); 2017;23:e68\u201375.","DOI":"10.1158\/1078-0432.CCR-17-0547"},{"key":"315_CR32","doi-asserted-by":"crossref","unstructured":"Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, et al. Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis. PLoS One. Public Library of Science (PLoS); 2012;7:e35711.","DOI":"10.1371\/journal.pone.0035711"},{"key":"315_CR33","doi-asserted-by":"crossref","unstructured":"Reilly KM, Kim A, Blakely J, Ferner RE, Gutmann DH, Legius E, et al. Neurofibromatosis Type 1\u2013Associated MPNST State of the Science: Outlining a Research Agenda for the Future. JNCI J Natl Cancer Inst. Oxford University Press (OUP); 2017;109.","DOI":"10.1093\/jnci\/djx124"},{"key":"315_CR34","doi-asserted-by":"crossref","unstructured":"Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, et al. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood. Clin Cancer Res. American Association for Cancer Research; 2017;23:e32\u2013e37.","DOI":"10.1158\/1078-0432.CCR-17-0574"},{"key":"315_CR35","doi-asserted-by":"crossref","unstructured":"Gibson LM, Paul L, Chappell FM, Macleod M, Whiteley WN, Salman RA-S, et al. Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis. BMJ. BMJ Publishing Group; 2018;363:k4577.","DOI":"10.1136\/bmj.k4577"},{"key":"315_CR36","doi-asserted-by":"crossref","unstructured":"Kwee RM, Kwee TC. Whole-Body MRI for Preventive Health Screening: A Systematic Review of the Literature. J Magn Reson Imaging. John Wiley & Sons, Ltd; 2019;jmri.26736.","DOI":"10.1002\/jmri.26736"},{"key":"315_CR37","doi-asserted-by":"crossref","unstructured":"Goehde SC, Hunold P, Vogt FM, Ajaj W, Goyen M, Herborn CU, et al. Full-Body Cardiovascular and Tumor MRI for Early Detection of Disease: Feasibility and Initial Experience in 298 Subjects. 2005;18418405:598\u2013611.","DOI":"10.2214\/ajr.184.2.01840598"},{"key":"315_CR38","first-page":"387","volume":"32","author":"D Baumgart","year":"2007","unstructured":"Baumgart D, Egelhof T. Pr\u00e4ventives Ganzk\u00f6rperscreening unter Einbeziehung moderner Bildgebung mit Hilfe der Magnetresonanztomographie. Herz Kardiovaskul\u00e4re Erkrankungen Urban & Vogel. 2007;32:387\u201394.","journal-title":"Herz Kardiovaskul\u00e4re Erkrankungen Urban & Vogel"},{"key":"315_CR39","doi-asserted-by":"crossref","unstructured":"Perkins BA, Caskey CT, Brar P, Dec E, Karow DS, Kahn AM, et al. Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults. Proc Natl Acad Sci U S A. National Academy of Sciences; 2018;115:3686\u20133691.","DOI":"10.1073\/pnas.1706096114"},{"key":"315_CR40","doi-asserted-by":"crossref","unstructured":"Hou YCC, Yu HC, Martin R, Cirulli ET, Schenker-Ahmed NM, Hicks M, et al. Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging. Proc Natl Acad Sci U S A. National Academy of Sciences; 2020;117:3053\u20133062.","DOI":"10.1073\/pnas.1909378117"},{"key":"315_CR41","unstructured":"Lo GG, Ai V, Au-Yeung KM, Chan JKF, Li KW, Chien D. Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors. Hong Kong Med J = Xianggang yi xue za zhi. 2008;14:90\u20136."},{"key":"315_CR42","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00330-009-1674-1","volume":"20","author":"T Takahara","year":"2010","unstructured":"Takahara T, Kwee T, Kibune S, Ochiai R, Sakamoto T, Niwa T, et al. Whole-body MRI using a sliding table and repositioning surface coil approach. Eur Radiol Springer. 2010;20:1366\u201373.","journal-title":"Eur Radiol Springer"},{"key":"315_CR43","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00330-012-2636-6","volume":"23","author":"K Hegenscheid","year":"2013","unstructured":"Hegenscheid K, Seipel R, Schmidt CO, V\u00f6lzke H, K\u00fchn J-P, Biffar R, et al. Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol. 2013;23:816\u201326.","journal-title":"Eur Radiol"},{"key":"315_CR44","doi-asserted-by":"crossref","unstructured":"Cieszanowski A, Maj E, Kulisiewicz P, Grudzinski IP, Jakoniuk-Glodala K, Chlipala-Nitek I, et al. Non-Contrast-Enhanced Whole-Body Magnetic Resonance Imaging in the General Population: The Incidence of Abnormal Findings in Patients 50 Years Old and Younger Compared to Older Subjects. Villa E, editor. PLoS One. Public Libr Sci; 2014;9:e107840.","DOI":"10.1371\/journal.pone.0107840"},{"key":"315_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2478\/raon-2014-0031","volume":"49","author":"DL Tarnoki","year":"2015","unstructured":"Tarnoki DL, Tarnoki AD, Richter A, Karlinger K, Berczi V, Pickuth D. Clinical value of whole-body magnetic resonance imaging in health screening of general adult population. Radiol Oncol De Gruyter Open. 2015;49:10\u20136.","journal-title":"Radiol Oncol De Gruyter Open"},{"key":"315_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.12659\/PJR.897570","volume":"81","author":"S Ulus","year":"2016","unstructured":"Ulus S, Suleyman E, Ozcan UA, Karaarslan E. Whole-body MRI screening in asymptomatic subjects; preliminary experience and long-term follow-up findings. Polish J Radiol Termedia Publishing. 2016;81:407\u201314.","journal-title":"Polish J Radiol Termedia Publishing"},{"key":"315_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10689-017-9965-1","volume":"16","author":"S Saya","year":"2017","unstructured":"Saya S, Killick E, Thomas S, Taylor N, Bancroft EK, Rothwell J, et al. Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls. Fam Cancer Springer. 2017;16:433\u201340.","journal-title":"Fam Cancer Springer"},{"key":"315_CR48","doi-asserted-by":"crossref","unstructured":"Lee SY, Park HJ, Kim MS, Rho MH, Han CH. An initial experience with the use of whole body MRI for cancer screening and regular health checks. Chen X, editor. PLoS One. Public Libr Sci; 2018;13:e0206681.","DOI":"10.1371\/journal.pone.0206681"},{"key":"315_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejrad.2008.08.006","volume":"72","author":"SHX Morin","year":"2009","unstructured":"Morin SHX, Cobbold JFL, Lim AKP, Eliahoo J, Thomas EL, Mehta SR, et al. Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol. Elsevier BV. 2009;72:529\u201333.","journal-title":"Eur J Radiol. Elsevier BV"},{"key":"315_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s13244-012-0180-1","volume":"3","author":"M Laible","year":"2012","unstructured":"Laible M, Schoenberg SO, Weckbach S, Lettau M, Winnik E, Bischof J, et al. Whole-body MRI and MRA for evaluation of the prevalence of atherosclerosis in a cohort of subjectively healthy individuals. Insights Imaging Springer. 2012;3:485\u201393.","journal-title":"Insights Imaging Springer"},{"key":"315_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1148\/radiology.153.1.6089263","volume":"153","author":"WT Dixon","year":"1984","unstructured":"Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189\u201394.","journal-title":"Radiology."},{"key":"315_CR52","unstructured":"Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, et al. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging. JAMA Oncol. American Medical Association; 2017;3:1634."},{"key":"315_CR53","doi-asserted-by":"crossref","unstructured":"Guo BJ, Yang ZL, Zhang LJ. Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives. Front Mol Neurosci. Frontiers Media SA; 2018;11:335.","DOI":"10.3389\/fnmol.2018.00335"},{"key":"315_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1593\/neo.81328","volume":"11","author":"AR Padhani","year":"2009","unstructured":"Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia Neoplasia Press. 2009;11:102\u201325.","journal-title":"Neoplasia Neoplasia Press"},{"key":"315_CR55","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2214\/AJR.14.13663","volume":"205","author":"SA Anupindi","year":"2015","unstructured":"Anupindi SA, Bedoya MA, Lindell RB, Rambhatla SJ, Zelley K, Nichols KE, et al. Diagnostic performance of whole-body MRI as a tool for Cancer screening in children with genetic Cancer-predisposing conditions. Am J Roentgenol American Roentgen Ray Society. 2015;205:400\u20138.","journal-title":"Am J Roentgenol American Roentgen Ray Society"},{"key":"315_CR56","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1158\/1078-0432.CCR-17-0515","volume":"23","author":"M-LC Greer","year":"2017","unstructured":"Greer M-LC, Voss SD, States LJ. Pediatric Cancer predisposition imaging: focus on whole-body MRI. Clin Cancer Res American Association for Cancer Research. 2017;23:e6\u201313.","journal-title":"Clin Cancer Res American Association for Cancer Research"},{"key":"315_CR57","first-page":"228","volume":"284","author":"H MacMahon","year":"2017","unstructured":"MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT images: from the Fleischner society 2017. Radiology. Radiological Society of North America. 2017;284:228\u201343.","journal-title":"Radiology. Radiological Society of North America"},{"key":"315_CR58","first-page":"475","volume":"292","author":"SG Silverman","year":"2019","unstructured":"Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, et al. Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology Radiological Society of North America. 2019;292:475\u201388.","journal-title":"Radiology Radiological Society of North America"},{"key":"315_CR59","doi-asserted-by":"crossref","unstructured":"Tanaka M, Fern\u00e1ndez-del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. Elsevier B.V.; 2017. p. 738\u201353.","DOI":"10.1016\/j.pan.2017.07.007"},{"key":"315_CR60","unstructured":"Incidental Findings | American College of Radiology [Internet]. [cited 2019 Nov 30]. Available from: https:\/\/www.acr.org\/Clinical-Resources\/Incidental-Findings."},{"key":"315_CR61","doi-asserted-by":"crossref","unstructured":"Blanks RG, Wallis MG, Alison R, Kearins O, Jenkins J, Patnick J, et al. Impact of Digital Mammography on Cancer Detection and Recall Rates: 11.3 Million Screening Episodes in the English National Health Service Breast Cancer Screening Program. Radiology. Radiological Society of North America; 2019;290:629\u201337.","DOI":"10.1148\/radiol.2018181426"},{"key":"315_CR62","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","volume":"3","author":"ML Ballinger","year":"2017","unstructured":"Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, et al. Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging. JAMA Oncol. 2017;3:1634.","journal-title":"JAMA Oncol"},{"key":"315_CR63","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00330-012-2723-8","volume":"23","author":"CO Schmidt","year":"2013","unstructured":"Schmidt CO, Hegenscheid K, Erdmann P, Kohlmann T, Langanke M, V\u00f6lzke H, et al. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study. Eur Radiol Springer-Verlag. 2013;23:1343\u201351.","journal-title":"Eur Radiol Springer-Verlag"},{"key":"315_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10654-015-0101-y","volume":"31","author":"CO Schmidt","year":"2016","unstructured":"Schmidt CO, Sierocinski E, Hegenscheid K, Baumeister SE, Grabe HJ, V\u00f6lzke H. Impact of whole-body MRI in a general population study. Eur J Epidemiol Springer Netherlands. 2016;31:31\u20139.","journal-title":"Eur J Epidemiol Springer Netherlands"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-020-00315-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T19:30:29Z","timestamp":1620675029000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-020-00315-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1186\/s40644-020-00315-0","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}